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Abstract: Cas3 is a ssDNA-targeting nuclease-helicase essential for class 1 prokaryotic CRISPR
immunity systems, which has been utilized for genome editing in human cells. Cas3-DNA crystal
structures show that ssDNA follows a pathway from helicase domains into a HD-nuclease active site,
requiring protein conformational flexibility during DNA translocation. In genetic studies, we had
noted that the efficacy of Cas3 in CRISPR immunity was drastically reduced when temperature was
increased from 30 ◦C to 37 ◦C, caused by an unknown mechanism. Here, using E. coli Cas3 proteins,
we show that reduced nuclease activity at higher temperature corresponds with measurable changes
in protein structure. This effect of temperature on Cas3 was alleviated by changing a single highly
conserved tryptophan residue (Trp-406) into an alanine. This Cas3W406A protein is a hyperactive
nuclease that functions independently from temperature and from the interference effector module
Cascade. Trp-406 is situated at the interface of Cas3 HD and RecA1 domains that is important for
maneuvering DNA into the nuclease active site. Molecular dynamics simulations based on the
experimental data showed temperature-induced changes in positioning of Trp-406 that either blocked
or cleared the ssDNA pathway. We propose that Trp-406 forms a ‘gate’ for controlling Cas3 nuclease
activity via access of ssDNA to the nuclease active site. The effect of temperature in these experiments
may indicate allosteric control of Cas3 nuclease activity caused by changes in protein conformations.
The hyperactive Cas3W406A protein may offer improved Cas3-based genetic editing in human cells.
Keywords: helicase; Cas3; CRISPR; genome editing
1. Introduction
Prokaryotes have evolved multiple defence strategies against incursion from mobile
genetic elements (MGEs, e.g., bacteriophage), including activation of their CRISPR-Cas
systems. These comprise a DNA locus called ‘CRISPR’ (Clustered Regularly Interspaced
Short Palindromic Repeats) and genes encoding ‘Cas’ (CRISPR associated) proteins, and
sometimes additional non-Cas proteins. Comprehensive recent perspectives of CRISPR
systems can be found in [1–3], and the references therein. Functional interaction and
co-operation between CRISPR DNA and its transcribed RNA (crRNA) and Cas proteins
generate immunity against future infection by the same or similar MGEs (CRISPR ‘Adapta-
tion’) and destroy the MGE (CRISPR ‘Interference’). For the latter, two major activities are
needed—an effector ribonucleoprotein complex to target crRNA to MGE DNA or RNA
via base-pairing, and a nuclease that degrades the MGE. Interference reactions in class 1
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CRISPR-Cas systems such as that of E. coli — CRISPR classifications can be found in [4]—
are catalyzed by Cascade complex and the Cas3 nuclease-helicase that are both essential
for efficacious defence against MGEs [5]. Cascade scans duplex DNA until it encounters a
trinucleotide sequence termed a protospacer adjacent motif (PAM) that stabilizes it into a
‘seed’ complex [6–11]—PAMs and other nucleic acid motifs involved in the functioning of
CRISPR systems are reviewed in [12]. The composition of the PAM sequence that is recog-
nized by any given Cascade complex is determined from the CRISPR adaptation reaction
that builds immunity, by inserting an MGE ‘protospacer’ DNA into a CRISPR locus in a
specific orientation—adaptation processes were reviewed recently in [13–15]. Recognition
of PAM and the ‘seed’ reaction by Cascade trigger formation of an R-loop (‘RNA-loop’)
complex in which Cascade base-pairs crRNA with a ‘targeted’ strand of DNA duplex,
and the other ‘non-targeted’ DNA strand is displaced as ssDNA [16]—the importance
of R-loops in biology is reviewed recently in [17]. In CRISPR systems, Cas3 is recruited
to the Cascade R-loop complex and degrades DNA, processes reviewed recently in [18].
Therefore, Cas3 destroys MGE DNA and in the process generates DNA fragments that may
prime adaptation [19], by their capture and integration into CRISPR DNA, completing a
virtuous cycle of CRISPR activities.
Control of the Cas3 nuclease-helicase activity is exerted at several junctures. Transcrip-
tion of E. coli ygcB (encoding Cas3) is repressed by H-NS, reviewed in [20], and CRP [21],
but de-repressed by LeuO [22,23], and activated by addition to cells of N5, N10-methylene
tetrahydrofolate, a product of bacterial glycine metabolism catalysed by enzymes of the
Glycine Cleavage System [24]. The presence of the stress-responsive chaperone protein
tHpG) is necessary for maintaining functional quantities of Cas3 in E. coli for CRISPR
interference [25], and interaction with the Cascade-R-loop complex may constrain Cas3
activity until adaptation proteins (Cas1-Cas2) are also present [8], although this may not
be the case in all Cascade-Cas3 containing systems. In E. coli, removal of H-NS (∆hns)
gives constitutive expression of Cas3 and Cascade that protects against λ phage plaques at
30 ◦C, but protection is lost at 37 ◦C [26]. The loss of CRISPR defence at 37 ◦C was reversed
by ectopic overexpression of Cas3 protein [26]. It was known from the earliest studies of
CRISPR systems that Cas3 is essential for defence against phage [5]—these latest genetic
studies revealed a switch-like function for Cas3 that could be exposed by altering cell
temperature. In this work, we investigated the mechanism of this property by analysis of
Cas3 proteins, identifying key conserved tryptophan residues that are responsible by acting
as a ‘gate’ to the passage of DNA into the nuclease active site. This provides experimental
support for a structural analysis of Cas3 presented in [27], in which it was predicted that a
tryptophan in this region of Cas3 may be important for protein activity.
2. Results
2.1. Cas3 Nuclease Activity Is Modulated by Temperature Changes That Correspond with
Conformational Re-Arrangement of Cas3 in Transition from 30 ◦C to 37 ◦C
In CRISPR systems Cas3 nuclease is targeted to destruction of MGEs, and potentially
provides MGE DNA as protospacers for updating the CRISPR immunity locus. In E. coli,
we previously reported that the efficacy of CRISPR defence against phage λ is restricted
by temperature [26,28]. This can be seen as increasing frequencies of phage λ plaques at
35–37 ◦C on lawns of ∆hns E. coli cells expressing Cas3, Cascade and λ-targeting crRNA
when compared with plaques at 30 ◦C (Figure 1A). This effect was suppressed by ectopic
(plasmid) over-expression of Cas3, compared to a control plasmid lacking cas3 (Figure 1B).
We investigated the mechanism for this effect using purified Cas3 proteins. E. coli wild-type
Cas3 was purified fused to tandem (His)6- maltose binding protein (MBP) affinity tags,
the latter to improve protein solubility and stability when expressed in E. coli [29,30]. It
was clear from initial assays of Cas3 nuclease activity against a Cy5 end-labelled fork DNA
(20 nM, Figure S1) that Cas3 (56 nM) was significantly more active at 30 ◦C compared to
37 ◦C (Figure 1C, compare panels i and ii). This DNA fork is a substrate for Cas3 nuclease
targeting the 3’ ssDNA end. In denaturing gels (Figure 1C, panels iii and iv) this was
apparent as removal of a few nucleotides at the 3’ end, giving the observed products
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because of the position of the 5’ Cy5 label—again nuclease activity was much reduced at
37 ◦C compared to 30 ◦C. This was consistent with the genetic data showing that E. coli is
more susceptible to λ plaque formation at 37 ◦C because Cas3 is required for protection
against them.
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Figure 1. Temperature-induced changes to Cas3 structure and function in E. coli cells and in vitro.
(A) ∆vir plaque formation was measured at 30-37 ◦C as a read-out for the efficacy of CRISPR
interference. Plaques (PFU, plaque forming units) were readily observed at and above 35 ◦C (see
also part B). Assays were in triplicate and standard errors from the mean are shown. (B) (i) Plaques
formed as measured in part A at 37 ◦C were not observed if the cells also over-expressed Cas3 from a
pl mid (ii, +pCas3), compared with the empty plasmid vector (pUC19) used s a control (iii). (C)
Cas3 nuc ease activity degra es Cy5 end-labelled (25 nM, label de oted by a star) DNA much more
effectively at 30 ◦C compared to 37 ◦C, in reactions containing 56 nM of Cas3 with samples taken at 0,
5, 15, 30, 60, 120 and 240 min. Panels i and ii show native TBE polyacrylamide gels, and iii and iv are
denaturing (urea) TBE gels. (D) Shows the Boltzmann curve traces from each of three independent
experiments for E. coli Cas3, derived from circular dichroism spectroscopy measurements at 222 nm.
The mean temperature for the inflection point is shown—34.75 ◦C—and see Supplementary Figure
S2 for the full plotted data.
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We investigated in more detail why Cas3 behaves in this temperature-sensitive way,
reasoning that Cas3 may undergo temperature-induced conformational changes. Circular
dichroism (CD) spectra were generated to detect changes in Cas3 secondary structure
composition and thermodynamics when heated from 20 ◦C to 55 ◦C. This yielded thermo-
grams of CD spectra changes at 222 nm, for alpha-helix and beta-strand composition [31],
that, from three independent experiments, fitted to a Boltzmann equation gave a thermal
inflection point at a mean of 34.75 ◦C with standard error +/−0.28 ◦C, summarized in
Figure 1D with additional data in Figure S2. CD data were analyzed using the DichroWeb
server [32], BeStSel [33] and CONTIN [34] to compare Cas3 protein secondary structure
composition either side of the thermal inflection point at 34 ◦C, showing substantial change
in α-helical and β-strand content (Table 1).
Table 1. Cas3 secondary structure from CD measurements at either side of the inflection point.a.
Secondary Structure % Composition inCas3 at 30 ◦C
% Composition in
Cas3 at 35 ◦C
Change
(∆)
α-Helix 18.1 14.3 −3.8
β-antiparallel 11.7 14.9 3.2
β-parallel 0.0 0.0 0
Turn 20.5 20.5 0
Other 49.7 50.3 0.6
a Results obtained in Bestsel for spectra range 200–250 nm.
These data show temperature-dependent changes in Cas3 structure that correlate well
with changes in nuclease activity and the function of Cas3 in CRISPR defence at 30 ◦C,
which becomes inactivated at 37 ◦C (Figure 1A). We next used available crystal structures
of Cas3 proteins to investigate in more detail the link between Cas3 nuclease activity,
conformational movement and temperature.
2.2. A Single Tryptophan Residue (Trp-406) Modulates the Cas3 Nuclease Activity
Amino acid substitutions were made to Cas3 to identify the underlying factors that
are responsible for the temperature dependent-nuclease activity and structural changes.
The atomic resolution structure of E. coli Cas3 is not available, so we turned to the I-E
subtype Cas3-DNA co-structures from Thermobifida fusca (PDB 4QQW-Z) [27] as a close
homologue of the E. coli Cas3—30% amino acid identity, E-value 7e−54—to identify areas
for mutagenesis. Many Cas3 proteins comprise a fusion of an HD-nuclease domain with
superfamily 2 helicase (RecA-like) domains and an additional predicted C-terminal domain
of unknown function (Figure 2A), reviewed recently in [18]. The interface between Cas3
HD and RecA1-like domains (iHDA1) includes a ssDNA binding channel in the vicinity
of helicase motifs Ib and Ic, which interacts with ssDNA in superfamily 2 helicases, that
leads to the HD nuclease active site (Figure 2A,B). The iHDA1 has been predicted to have
conformational flexibility for reorientation of ssDNA when gaining access to the nuclease
active site [27,35]. We targeted two tryptophan residues that are highly conserved across
bacterial Cas3 proteins (Figure 2C), one located in the iHDA1 (Trp-406 in E. coli Cas3
numbering) and the other (Trp-230) located close by (Figure 2A,B), and both of which are
predicted to interact with ssDNA [27].
Mutant Cas3 proteins were purified with amino acid substitutions in Trp-230 or Trp-
406, and in two further residues, Trp-149 and Trp-152, that, although located close to
Trp-230 and Trp-406 (Figure 2B), are much less well conserved across species and were
used in comparison with Trp-230/406. We therefore purified mutant proteins Cas3W230A,
Cas3W406A, Cas3W149A and Cas3W152A for assays measuring their nuclease activity com-
pared to the wild type protein. Using the DNA fork (20 nM) substrate and measured
as a function of time, wild type Cas3 (56 nM) converted maximally 92% of DNA into
nuclease product at 30 ◦C, compared to 40% at 37 ◦C (Figure 2D). Cas3W149A, Cas3W152A
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and Cas3W230A (all at 56 nM) were significantly less active than wild type Cas3 at both
temperatures. However, Cas3W406A (56 nM) was active similarly to wild type Cas3 at 30 ◦C
and hyperactive compared to wild type Cas3 at 37 ◦C (mean of 73% fork converted to
nuclease product). Therefore, the Cas3 Trp-406 residue seemed to modulate Cas3 nucle-
ase activity because changing it to alanine substantially overcame the inhibitory effect
of elevated temperature on nuclease activity. There was no evidence in Electrophoretic
Mobility Shift Assays (EMSAs) for Cas3W406A binding to DNA more stably or with greater
efficacy than wild type Cas3 (Figure S3 panels (i and (ii), although the mutant proteins with
reduced nuclease activity (Cas3W149A, Cas3W152A and Cas3W230A) formed less pronounced
protein-fork DNA complex in the same EMSAs (Figure S3 panels iii–vi).
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Figure 2. Structural positioning of two invariant tryptophan residues at the interface of Cas3 HD
and RecA1 domains—a key role in Cas3 nuclease function for Trp-406. (A) Cartoon representation of
Cas3 protein with amino acid residues indicated for the nuclease (HD) and Walker B ATPase active
sites using numbering from the E. coli protein. Highlighted n the foreground is the region deta led in
the r sults, located at the interface of HD and RecA1 domains (‘iHDA1’) and including the ssDNA
binding helicase motifs Ib and Ic. (B) E. coli Cas3 structure deduced from T. fusca Cas3 (PDB: 4QQW)
and T. terrenum (PDB: 4Q2C) (27,35) highlighting the tryptophan residue W406 (labelled) and the
passage of ssDNA (tan cord). Cas3 regions are denoted as follows in the same way as in part A: HD
(orchid), RecA1 (green), RecA2 (orange), an interdomain linker helix (purple) and the CTD (blue).
Grey spheres indicate the HD nuclease active site residues. (C) Sequence alignment highlighting
conservation of residues Trp-406 and Trp-230 in Escherichia coli K-12 (Eco) with the structurally
determined Cas3 proteins from T. fusca (Tfu) and T. terrenum (Tter) proteins. Protein sequences were
aligned using Clustal Omega and results were exported via Lasergene 17. (D) Nuclease activity of
Cas3 and mutants (56 nM) measured on the DNA fork substrate (20 nM). Samples were collected at 0,
5, 15, 30, 60, 120 and 240 min. Reactions were carried out in triplicate at 30 ◦C or 37 ◦C as indicated,
and data points show standard errors from the mean.
2.3. Evidence That Trp-406 Is a ‘Gate’ in Cas3 That Controls Access of ssDNA to the Nuclease
Active Site
When E. coli Cas3W406A was assessed using CD and BeStSel in the same way as for
wild type Cas3, we observed the thermal melting/inflection point increased from 34.75 ◦C
to 36.7 ◦C (Figure S4), accompanied by changes in β-strand that were significantly different
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from those observed for wild type Cas3 (Table 2). We next used molecular dynamics
simulations focusing on Trp-406 to investigate why the Cas3W406A protein may behave in
this way.
Table 2. Cas3W406A secondary structure from CD measurements at either side of the inflection point.a.
Secondary Structure % Composition inCas3W406A at 30 ◦C
% Composition in
Cas3W406A at 35 ◦C
Change
(∆)
α-helix 22.1 12.8 −9.3
β-antiparallel 22.0 22.8 0.8
β-parallel 6.5 3.7 −2.8
Turn 10.3 11.7 1.4
Other 39.1 49.0 9.9
a Results obtained in Bestsel for spectra range 200–250 nm.
In the Cas3 crystal structure from T. fusca (PDB 4QQW) [27], the tryptophan equivalent
to E. coli Cas3 Trp-406 is abutted to another tryptophan residue (Trp-230 in E. coli). This Trp-
230/406 pair is close to the ssDNA binding channel in the iHDA1 (Figure 2B,C). We used
this structure and that of Cas3 from Thermobaculum terrenum (PDB 4Q2C) [35] to generate
via SWISS-MODEL [36] a predicted structure for E. coli Cas3 to begin molecular dynamics
simulations of these tryptophan residues at 30 ◦C and at 37 ◦C. In molecular dynamics
simulations, we identified temperature dependence for interaction of the highly conserved
residues Trp-406 and Trp-230. Increasing temperature resulted in increased distance, from
a mean of approximately 6.1 Å at 30 ◦C to 11.6 Å at 37 ◦C (Figure 3A and Figure S5A in
supporting material). When in close proximity (30 ◦C), Trp-230 and Trp-406 from a stable
π–π interaction that was broken in the first phase of MD simulations at 37 ◦C and remained
broken through the rest of simulations (Figure 3B). The interaction breaks because of
Trp-406 moving away from Trp-230 to a position close to the Ic helicase motif (Asn-Lys-Lys,
see also Figure 2A) comprising residues 411–413. There, Trp-406 is stabilized into a new
position by hydrophobic interactions with newly surrounding residues (Figure 3B, right
panel, Figure S5 in supporting material). At 30 ◦C in MD simulations, Trp-406 bound to
Trp-230 lies beside the ssDNA binding tunnel that connects the translocation motifs with
the HD nuclease active site (Figure 3C panel i). However, at 37 ◦C, positioning of Trp-406
forms an obstruction within the tunnel that would limit ssDNA access to the nuclease
active site (Figure 3C panel ii). Therefore, Trp-406 is acting as a gate to control access of
ssDNA to the nuclease active site. This provides a molecular explanation for lower activity
of Cas3 as a nuclease at 37 ◦C compared to 30 ◦C, and why Cas3W406A is hyperactive as a
nuclease at 37 ◦C—replacement of Trp-406 with alanine would have the effect of leaving
the gate open for passage of ssDNA.
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coloured in red. At 37 °C Trp-406 moves to a location within a pocket in the ssDNA tunnel. 
Figure 3. Molecular dynamics simulations indicate significant temperature-induced changes in
positioning of Trp-230 and Trp-406. (A) Shows the distances between the centre of phenyl rings of
Trp-230 and Trp-406 mo itor d during the simulations at 30 ◦C and 37 ◦C, as indicated. (B)
Structures obtained during the final phase of MD simulations. The panel left side shows the Trp-230
and Trp-406 π-π interaction at 30 ◦C that is disrupted at 37 ◦C (panel right) because Trp-406 is moved
into the pocket where it is stabilized by hydrophobic interactions within the ssDNA tunnel, shown as
surfaces representing Thr-392, Gln-402, Gln-405, Leu-407, Gln-409, Lys-412, Lys-435, His-436, Asp-780
and Asp-778. (C) Temperature-induced chang s in the posi i ning of Trp-230 and Trp-406 re ult in
Trp-406 movement and blockage of the ssDNA binding channel (shown as grey surfaces representing
the residues that form it), which we propose explains the lack of nuclease activity shown by E. coli
Cas3 at the higher temperature, and its alleviation by replacing tryptophan with alanine. Cas3 protein
is coloured in Cyan and Trp-230 and Trp-406 are coloured in red. At 37 ◦C Trp-406 moves to a location
within a pocket in the ssDNA tunnel.
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2.4. Hyperactivity of Cas3W406A Nuclease Is Independent of Cas3 ATPase Activity and of the
Cascade Complex
CRISPR interference requires Cas3 nuclease and ATP-dependent DNA translocase
activities [5,37]. Structural models of Cas3 function describe ATPase activity that powers
protein conformational movement that results in translocation of ssDNA into the HD
nuclease active site, via the ssDNA binding channel through the helicase domains. As
noted above (Figure 2C), Trp-406 is located close to the nuclease active site and the ssDNA
channel, at the interface with domain RecA1 that contains the ATPase active sites. We
therefore tested if Cas3W406A was also a hyperactive ATPase that, based on the structural
models, may explain hyperactive nuclease activity. Cas3 ATP hydrolysis was measured
using the malachite green reporter assay [38] at 30 ◦C and 37 ◦C, compared to reactions
lacking Cas3. In contrast to nuclease activity, temperature had no significant effect on
wild type Cas3 ATPase activity (Figure 4A). ATPase activity of each Cas3 mutant was
similar whether measured at 30 ◦C or 37 ◦C, also contrasting with the much-reduced
nuclease activity from three of the mutants at the higher temperature. Cas3W406A was not
hyperactive as an ATPase at 37 ◦C. Therefore, the effect of temperature and the Trp-406
residue are exerted only on Cas3 nuclease activity.
In E. coli CRISPR interference, Cas3 is recruited to MGE DNA at an R-loop formed by
the Cascade ribonucleoprotein complex [16]. Cas3 then degrades the non-targeted MGE
DNA strand [8,19,39–42]. The Cas3 nuclease reaction is in two steps, first, magnesium-
dependent nicking of supercoiled DNA [8,40], and then ATP-dependent translocation
of ssDNA to power processive nucleolytic digestion [37,43]. The interplay of Cas3 and
Cascade in interference reactions led us to test for Cas3 and Cas3W406A nuclease activities
against a plasmid targeted by Cascade in vitro (Figure 4B). The Cascade apo-protein
complex was purified and activated by binding to a targeting CRISPR RNA (crRNA)—the
complex targets M13 double-stranded supercoiled DNA to form an R-loop, seen as a slower
migrating M13 species compared to reactions lacking Cascade (Figure 4B, compare lanes 2
and 3) [44]. Cas3 converted supercoiled M13 nto nicked and linearized DNA in reactions
dependent on magnesium (compare lanes 4 and 5), and the same effect was observed
using Cas3W406A instead of wild type Cas3 (lane 6). An interesting result was observed
when Cascade R-loops were pre-formed on M13 DNA—in these reactions, wild type Cas3
nuclease activity was inhibited by Cascade, observed as the absence of linearized M13
and re-appearance of supercoiled M13 (Figure 4B lane 7), but activity of Cas3W406A in this
respect was unaffected by Cascade (lane 8).
Assays comparing Cas3 and Cas3W406A nuclease activity in the presence of Cascade
were repeated with the addition of ATP, to observe for processive nucleolytic degradation
of the M13 DNA (Figure 4C). Consistent with a previous analysis of CRISPR interference
in vitro [29], reactions containing Cascade, wild type Cas3 and Mg-ATP gave an accumula-
tion of nicked DNA (Figure 4C, compare lanes 3–5 with lanes 1 and 2). In contrast, though,
Cas3W406A generated products consistent with processive nuclease activity (Lane 6), uncou-
pled from the constraint of Cascade. This intriguing observation indicates that the nuclease
hyperactivity of Cas3W406A can also overcome the modulating effect of Cascade in vitro.
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2.5. Cas3W406A Does Not Protect E. coli Cells from Phage Lysis. 
Finally, we evaluated if Cas3W406A nuclease hyperactivity impacted CRISPR cata-
lyzed protection against phage lambda (λvir). The assay requires expression of Cas3 and 
Cascade in E. coli to determine if these cells are resistant to lambda plaque formation 
Figure 4. Nuclease hyperactivity of Cas3W406A is independent of ATPase activity and interaction
with Cascade. (A) End-point measurements of ATP hydrolysis by Cas3 proteins (790 nM) was
co pared at 30 and 37 ◦C as indicated. Reactions were in triplicate, standard errors from the mean
are sho n, to give measurements of phosphate (Pi) released from per nM of Cas3 protein. These
values were obtained from spectroscopic measurements of malachite green dye intensity, shown in
the graph, each measurement was obtained after blanking the spectrophotometer with reactions
lacking Cas3. (B) Shows Mg2+-dependent DNA nicking activity of Cas3 and Cas3W406A (85 nM) on
13 DNA in reactions that contain preformed Cascade (100 nM) R-loop substrates, indicated by an *.
Reaction components are as indicated above the ethidium bromide stained agarose gel panel. In these
reactions no deproteinising ‘stop’ solution was added, so that we were able to visualise that Cascade
R-loops had formed (e.g., lane 3). (C) Shows Cas3 nicking and uclease activity in the presence of
Mg2+ and ATP and Cascade (100 nM), as indicated above the ethidium bromide stained agarose
gel pan l. These reactions w re st pped by adding proteinase K ‘stop’ solution to dissipate R-loops
so that nuclease products are more easily disc rned. For panels (B,C) the topology of the DNA is
highlighted to the right of the gel image by N (nicked) L (linear), * (R- oop) and ∆ (Supercoiled).
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2.5. Cas3W406A Does Not Protect E. coli Cells from Phage Lysis
Finally, we evaluated if Cas3W406A nuclease hyperactivity impacted CRISPR catalyzed
protection against phage lambda (λvir). The assay requires expression of Cas3 and Cascade
in E. coli to determine if these cells are resistant to lambda plaque formation [5,30]. The
CRISPR−1 locus of these cells was engineered to contain two anti-λvir spacers for targeting
of Cascade to λvir DNA. In addition, the native ygcB gene encoding wild type Cas3 within
the CRISPR-cas locus was replaced by the ygcBW406A allele, encoding Cas3W406A. Cells
were lacking H-NS (∆hns) to de-repress transcription of Cascade and Cas3 encoding genes.
At 30 ◦C, wild type Cas3 cells were fully protected from plaque formation when challenged
by λvir, but this protection was lost at 37 ◦C (Figure 5), as expected from Figure 1 and [28].
Cas3W406A cells showed λvir plaques at both temperatures, and, in addition, Cas3W406A
plaques were significantly larger than those of wild type Cas3 at 37 ◦C, further indicating
that the Cas3W406A mutation is ineffective for CRIPSR interference (Figure 5). We observed
no difference between the morphology or viability of unchallenged Cas3 or Cas3W406A
expressing cells that might explain the difference. Therefore, we conclude that, although
Cas3W406A is a hyperactive nuclease, its expression in cells is unable to deliver the CRISPR
effector response that protects against phages. This interesting phenomenon is discussed
below because it may highlight allosteric regulation of Cas3 in cells.
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∆hns (∆cas1) + λc + λT3 (IIB1309) a 06A ∆hns (∆cas ) (IIB1342) were infected with
phage dilutions (from 10−3 to 10−7) a d incubated at 30◦C and 37◦C as indicated. Bars represent
average and SD of the number of plaque forming units (PFUs) per ml from three independent
experiments. Also shown are corresponding photographs of typical bacterial lawns and viral plaques
giving the data.
3. Discussion
In this work, we found that temperature sensitivity of Cas3 nuclease in vitro is inde-
pendent of ATPase activity, with evidence that this is caused by positioning of a highly
conserved pair of tryptophan residues close to the nuclease active site. The in vitro data is
in agreement with previous genetic analysis identifying temperature sensitivity of Cas3 in
cellular defence against phage λ, which we can now attribute to the loss of Cas3 nuclease
function. The tryptophan residues (Trp-230/406) reside in a region of Cas3 we refer to as
iHDA1, a domain interface needed to channel ssDNA between the RecA1 helicase domain
and the HD nuclease active site. In a structural analysis of Cas3 [27], the DNA phosphate
backbone is described as undergoing extraordinary twisting in the iHDA1 in order to reach
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the HD active sites. Our analyses show that the position of Trp-406 in E. coli Cas3 may be
either ‘permissive’ or ‘inhibitory’ to ssDNA accessing the nuclease active site (Figure 6), and
that this alone may explain the temperature-sensitive behaviour of Cas3. CD spectroscopy
showed temperature-dependent changes in Cas3 secondary structure, including a major
effect at 34.75 ◦C consistent with a switch in protein conformation, and CD spectra changes
associated with mutating Trp-406 to alanine. In molecular dynamics simulations, we ob-
served that the Trp-406 R-group moves from lining the ssDNA binding channel of iHDA1
at 30 ◦C (DNA permissive), to forming a steric block to the channel at 37 ◦C (inhibitory).
Inhibition of nuclease activity at 37 ◦C was substantially overcome by replacing Trp-406
with alanine. In effect, the Cas3W406A mutation has generated a hyperactive Cas3 nuclease.
However, this mutation was disadvantageous to cells for CRISPR defence against phage
because replacement of the wild type cas3 allele on the E. coli chromosome with cas3W406A
made cells susceptible to phage lysis, seen as plaques on bacterial lawns. The invariance
of Trp-406 across bacterial Cas3 proteins is consistent with it holding a crucial role for
Cas3 function in CRISPR systems, which had not been previously identified, although a
structural study of Cas3 had highlighted this tryptophan as likely to be important in Cas3
function [27].
Cas3 structure therefore exerts intrinsic control over nuclease activity, via a gate formed
of Trp-406 opening and closing access of ssDNA to the nuclease active site (Figure 6).
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Figure 6. Concluding summary of the Trp-406 nuclease ‘gate’ model. (i) When Trp-406 is positioned
close to helicase motif Ic it blocks the ssDNA binding channel to the nuclease (HD) active site,
resulting in a ‘closed’ gate. In this scenario CRISPR interference is inhibited because MGE DNA
is not destroyed, resulting in cell lysis evident as plaques on a bacterial lawn. (ii) Conformational
movement of Cas3 re-positions Trp-406 proximally to Trp-230, with which it interacts to form a lining
to ssDNA channel in the gate being ‘open’. In this state Cas3 is able to degrade MGE DNA to fulfil
its role in CRISPR adaptation reactions.
This tryptophan residue, and its binding partner at lower temperature, Trp-230, is
well positioned for this, being close to the HD active site—a 12 Å mean distance from the
centre of mass of the Trp-406/Trp-230 pair and the HD active sites in MD simulations at
30 ◦C. Allosteric regulation of nucleases in biological systems ensures that they are targeted
to destroy only appropriate substrate nucleic acids at an appropriate time. For Cas3, the
interaction with Cascade during CRISPR interference provides targeting, and functional
levels of Cas3 in cells rely on the presence of the chaperone HtpG [25], another form of
post translational control over Cas3. In a speculative model, we suggest that HtpG may
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chaperone Cas3 via physical interaction that suppresses Cas3 nuclease activity until it
encounters the Cascade complex, with which it interacts physically through the Cse1/CasA
subunit. In this scenario, exchange of Cas3 from HtpG to Cascade is accompanied by
changes to the iHDA1 region tryptophan residues that allow ssDNA to be degraded,
equivalent to the effect we observe to be brought about by temperature changing from
37 ◦C to 30 ◦C. Therefore, the effect of temperature that we observe may be a proxy
for changes induced by HtpG. However, growth temperature and other environmental
factors have a profound effect on bacterial cell physiology [45], and therefore the effect
of temperature that we observe on Cas3 function may reflect environmental control of
CRISPR systems. Other factors could instead be involved, including post-translational
chemical modifications to Cas3 protein [46], although the known requirement for HtpG
and Cas3 to co-function in CRISPR immunity would make such an effect of HtpG the most
likely explanation at present. Further in vitro studies of Cas3 alongside HtpG, and Cascade
R-loops, should enable these ideas to be tested.
Bacterial Cas3 and Cascade have been deployed for genetic insertions or deletions
in human cells [47–49]. These reactions rely on the processive nuclease activity of Cas3
to delete up to 200 kb of DNA from the human cell chromosome targeted by the Cascade
complex, with potentially therapeutic uses [50]. The identification of hyperactive nuclease
Cas3W406A may be of use in this respect, particularly if it can be successfully targeted by
Cascade but then has nuclease activity that is not modulated by Cascade.
A concluding summary of the work presented here is shown in Figure 6.
4. Materials and Methods
4.1. E. coli Strains, Plasmids and Molecular Cloning
E. coli strains and their derivation are listed in Table S1. Plasmids and primers are
listed in Table S2. The gene encoding Cas3 (ygcB,) was amplified from E. coli MG1655
genomic DNA and cloned into pBAD-HisA (Thermo Fisher Scientific, U.K.) via XhoI and
EcoRI sites to construct plasmid pAH4 for overexpression and purification of Cas3 with
an N-terminal histidine tag. The plasmid for purification of (His)6-MBP-Cas3 protein was
described in [29]. Point mutants used in this study were created using a Q5 Site-Direct
Mutagenesis Kit (New England Biolabs) and plasmids were verified by Sanger sequencing
(Source Bioscience).
4.2. Protein Expression and Purification
Plasmid encoding ygcB with either a (His)6-MBP tag (pCas3) or (His)6-tag only (pAH4)
was transformed into BL21 A.I. (Invitrogen) and selected on agar containing 100 µg/mL
ampicillin. Cells were grown in LB broth with 100 µg/mL ampicillin at 37 ◦C until the
absorbance at 600 nm (OD600) reached 0.3 and L-arabinose 0.2% (w/v) was added at this
point to induce protein overexpression. Growth continued for another 3 h at 37 ◦C before
cells were resuspended in lysis buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 10% (v/v)
glycerol and 0.5 mM phenylmethylsulphonyl fluoride (PMSF)) and stored at −80 ◦C. Cells
were lysed and centrifuged at a relative centrifugal force of 48,000 g for 1 h at 4 ◦C.
Cell lysates containing over-expressed Histidine-tagged Cas3 were loaded onto Ni-
NTA resin pre-equilibrated with lysis buffer, and bound proteins washed with a further
buffer (50 mM Na3PO4 buffer pH 8.0, 300 mM NaCl, 20 mM imidazole). Proteins were
eluted from the resin via a linear gradient of increasing imidazole (50 mM to 125 mM)
in 50 mM Na3PO4 buffer pH 8.0 and 300 mM NaCl. Samples were analyzed by 10%
(w/v) SDS-PAGE and Western blotting with anti-histidine antibody (Monoclonal Anti-
polyhistidine-Peroxidase clone HIS-1, Sigma-Aldrich). Proteins were concentrated with
ultrafiltration in an Amicon Ultra 3K device (Merck) in 50 mM Na3PO4 buffer pH 8.0 and
stored at −80 ◦C.
Cell lysates containing over-expressed (His)6-MBP-Cas3 were loaded onto Ni-NTA
resin (GE Healthcare) pre-equilibrated with buffer A (20 mM Tris-HCl pH 8.0, 10 mM
imidazole, 100 mM NaCl, 10% (v/v) glycerol). The column was then washed with a further
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buffer (20 mM Tris-HCl pH 8.0, 10 mM Imidazole, 1 M NaCl, 10% (v/v) glycerol) and re-
equilibrated with buffer A. (His)6-MBP-Cas3 was directly eluted from Ni-NTA resin with
buffer B (20 mM Tris-HCl pH 8.0, 250 mM Imidazole, 100 mM NaCl, 10% (v/v) glycerol),
and recovered proteins were loaded into 1 mL heparin column (GE Healthcare, U.K.) and
then 1 mL MBPTrap HP column (GE Healthcare) both pre-equilibrated with buffer MA
(20 mM Tris-HCl pH 8.0, 100 mM NaCl). Cas3 did not bind to heparin column and therefore
the column flow through was loaded directly into the MBPTrap HP column. Proteins were
eluted from the MBPTrap HP column with buffer MB (20 mM Tris-HCl pH 8.0, 100 mM
NaCl, 10 mM maltose) and dialysed into buffer containing 20 mM Tris-HCl pH 8.0, 100 mM
NaCl and 30% (v/v) glycerol for storage at −80 ◦C.
4.3. DNA Substrate Preparation
The DNA fork substrate for evaluating Cas3 nuclease activity shown in Figure S1
was constructed by annealing 5 µM of each oligonucleotide MW12 and MW14 in buffer
comprising 10 mM Tris pH 7.5, 50 mM NaCl and 1 mM EDTA. The DNA was incubated at
95 ◦C for 10 min allowed to cool to 20 ◦C overnight. The annealed DNA fork was separated
from free oligonucleotides by migrating the sample on a 10% acrylamide 1 x TBE gel. The
band containing the fork substrate was excised, with annealed fork substrate eluted in
elution buffer (4 mM Tris pH 8.0 and 10 mM NaCl), followed by ethanol precipitation to
concentrate the fork substrate.
4.4. Protein-Nucleic Acid Assays
Cas3 proteins were incubated with 20 nM of fork DNA in buffer O (50 mM Tris-HCl
pH 7.5, 10 mM MgCl2, 100 mM NaCl, 0.1 mg/mL BSA, 20 mM DTT), at 30 or 37 ◦C.
Reactions were stopped by adding 50 mM Tris pH 8.0, 100 mM EDTA, 5 mg/mL proteinase
K and 1% (w/v) SDS, followed by incubation at 37 ◦C for 15 min. Reactions were mixed
with Orange G loading dye 1 (80% (v/v) glycerol, Orange G) for electrophoresis in 10%
acrylamide 1 x TBE gels, or Orange G loading dye 2 (20% v/v glycerol, 78% v/v formamide
and Orange G) for electrophoresis through 10% acrylamide denaturing gels.
For EMSAs, Cas3 proteins were incubated with 20 nM of fork DNA in buffer E (50 mM
Tris-HCl pH 7.5, 100 mM NaCl, 0.1 mg/mL BSA, 20 mM DTT), at room temperature
for 1 h. Reactions were mixed with 8 µL Orange G loading dye 1 (80% v/v glycerol and
Orange G) for electrophoresis in 10% acrylamide 1 x TB gel containing 0.13 M Tris-HCl
(pH 7.6), 45 mM boric acid, 8% acrylamide and 5 mM DTT. Running buffer containing
0.13 M Tris-HCl (pH 7.6), 45 mM boric acid, 5 mM DTT, and 0.1 mg/mL BSA was used
in EMSA.
For Cas3 nuclease reactions in the presence of Cascade, the Cascade complex was
prepared as described in [44]. The crRNA sequence, given in the supplementary informa-
tion, anneals to M13 RF I DNA. To analyse Cas3 nicking activity, 100 nM Cascade was first
pre-incubated with 50 ng of M13 RF I (supercoiled) DNA in buffer O (50 mM Tris-HCl
pH 7.5, 10 mM MgCl2, 100 mM NaCl, 0.1 mg/mL BSA, 20 mM DTT) at 30 or 37 ◦C for
30 min, to form an R-loop complex. Cas3 proteins were added and the mixture incubated
for a further 120 min before directly mixing with Orange G loading dye (80% v/v glycerol
and Orange G) and loading for electrophoresis through a 1% TAE agarose gel. If ATP was
to be included, it was added to a final concentration of 2 mM in the Cas3 protein sample.
All reactions were stopped using 50 mM Tris pH 8.0, 100 mM EDTA, 5 mg/mL proteinase
K and 1% SDS, before adding Orange G dye for electrophoresis in a 1% TAE agarose gel.
4.5. ATPase Assays
Cas3 ATPase assays followed the method described in [38] that uses malachite green
dye as a reporter for liberation of phosphate from ATP. Reactions were in buffer O (50 mM
Tris-HCl pH 7.5, 10 mM MgCl2, 100 mM NaCl, 0.1 mg/mL BSA, 20 mM DTT) supplemented
with 20 nM of MW14 ssDNA and 2.5 mM ATP. Reactions were incubated at either 30 ◦C
or 37 ◦C for 60 min before adding eight reaction volumes of pre-mixed colour reagent,
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incubating at room temperature for 2 min and stopping the reaction by adding one volume
of 3% (w/v) sodium citrate. Colour reagent was prepared using six volumes of 0.045% (w/v)
malachite green hydrochloride mixed with one volume of 4.2% (w/v) ammonium molybdate
in 4 M HCl. Samples were transferred to 96-well flat bottom plate (Life Technologies)
to measure phosphate production by dye absorbance at 660 nM. The total amount of
phosphate product (nmol) was calculated from a phosphate standard curve plotted using
NaH2PO4 at 2–16 nmol in 100 µL reactions developed as described above.
4.6. Phage Sensitivity Assay by Plaque Formation
This assay was done according to reference [26]. Cells were grown to saturation
overnight in LB medium at 37 ◦C with 0.2% (w/v) maltose. LB plates were overlaid with
3 mL of 0.6% (w/v) LB top agar containing 0.2 mL of cells. Then, 10 µL aliquots of serially
diluted λvir phage in 10 mM MgSO4 were spotted on the surface of set agar and allowed
to soak in. Plates were incubated overnight at 30 ◦C or 37 ◦C. The sensitivity of the cells
to infection was represented as the plaque-forming units (PFUs) by plaques from several
dilutions being counted and their number per ml calculated.
4.7. Construction of the Chromosomal Cas3 Point Mutant
The cas3W406A allele was made in pAH4 by site-directed mutagenesis to create plasmid
pIIB39—details of the primers and plasmids are in the supplementary material. This
was used to replace the wild type Cas3 allele in E. coli strain IIB1309 (T3 λc ∆cas1::FRT
∆hns::kan) using the gene replacement method described in [51]. The full Cas3 encoding
gene (ygcB) containing the mutation for W406A was cloned from plasmid pIIB39 into
the pKOV plasmid using the NEBuilder® HiFi DNA Assembly kit and primers listed in
Table 2 (oligos). The assembly reaction was prepared according to the manufacturer’s
recommendations and 2 µL of the mixture was transformed into NEB 5-alpha competent E.
coli cells and incubated over night at 30 ◦C. Transformed colonies were screened using PCR
and sequencing for the presence of the correct cas3 gene insert. Correct plasmid with the
insert was purified and transformed into the strain IIB1309 (λT3 λc ∆cas1::FRT ∆hns::kan)
and plated onto chloramphenicol agar to induce plasmid integration at 42 ◦C. From the
42 ◦ C plate, 1–2 colonies were picked into 3 mL of LB broth with 5% w/v sucrose, grown
over night at 37 ◦C and plated next day onto LB plate with 5% w/v sucrose to induce loss
of the replacement vector. Individual colonies were then tested by phage infection assay
and loss of antibiotic resistance. Colonies that showed plaques at 30 ◦C and sensitivity to
antibiotic chloramphenicol were selected. The cas3 gene was amplified and sequenced in
the Macrogen Europe service to confirm the point mutation.
4.8. Circular Dichroism Measurements and Analysis of Cas3 Secondary Structure
Circular dichroism (CD) measurements of purified (His)6-Cas3 used a Jasco J-815 CD
spectrophotometer connected to a Peltier temperature control system. Protein samples
were diluted in 50 mM sodium phosphate (pH 8.0) to a concentration of 0.1–0.2 mg/mL
in a total volume of 300 µL, for analysis in a 1 mm path length thermo-cuvette. Spectra
were measured from 190 nm to 260 nm, and at 222 nm, at 20 ◦C with continuous scanning
(50 nm/min) using a response time of 1 s and bandwidth of 1 nm. Delay was set at
30 s, sensitivity as standard and data pitch as 0.2 nm. For an assessment of the thermal
denaturation of Cas3 proteins, the CD ellipticity (mdeg) was recorded at 222 nm in the
temperature range from 20 ◦C to 55 ◦C for Cas3 and from 30 ◦C to 90 ◦C for archaeal Cas3
with a temperature slope of 1 ◦C/min and data pitch set as 1 ◦C or 5 ◦C, with delay of 30 s
for each temperature. The buffer CD signal was subtracted from all measurements. Data
were collected considering the HT voltage applied to detector was at the maximum of 600 V.
Data were processed and fitted to a Boltzmann sigmoidal curve using the Origin software.
Changes in the secondary structures of the Cas3 and Cas3W406A proteins were calculated
at two temperatures using the CD experimental data at Dichroweb [32], BeStSel [33] and
algorithm CONTIN with set 4 parameters (optimized for 190–240 nm) [32,34].
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4.9. Molecular Dynamics Simulations of Cas3 Protein
Starting models of Escherichia coli Cas3 were prepared from structures of Cas3 from
Thermobaculum terrenum (PDB ID: 4Q2C) [35] and Thermobifida fusca (PDB ID: 4QQW) [27]
using the SWISS-MODEL web server [36] (Figure S6 in supporting material). Polar hy-
drogen atoms were added using H++ [52] and WHATIF software [53] in order to obtain
an optimal hydrogen bonding network. Non-polar hydrogen atoms were added using
the tleap module of Amber16 program package [54]. Protein structures were placed in
the centre of the box filled with a TIP3P model of water molecules. Parameters for the
protein atoms, Mg2+ ions and DNA atoms were obtained from the Amber ff14SB and
the Amber OL15 force fields. Parameters for ATP were obtained from literature. Before
molecular dynamics (MD) simulations, systems were energy minimised in several cycles
using different constraints (the detailed procedure is described in [55]. During the first
250 picoseconds (ps) of MD simulations, temperature was linearly increased from 0 K
to final temperature (301 K, 303 K or 310 K, depending on the simulation), while, from
250 ps to 300 ps, temperature was kept constant. During the first 300 ps, volume was
kept constant, and solute atoms were constrained using a harmonic potential with a force
constant of 32 kcal/(mol·Å2). For the next 200 ps, the system was equilibrated at a constant
temperature under constant pressure using the weak coupling Berendsen thermostat al-
gorithm with the time constant for heat bath coupling set to 2 ps. During the production
phase, systems were simulated at constant pressure with a Berendsen thermostat [56]
and the time constant for heat bath coupling set to 1 ps. The time step of the simulation
was 1 fs and structures were sampled every 100 ps. Periodic boundary conditions (PBC)
were applied and electrostatic interactions were calculated using a particle mesh Ewald;
systems were made electroneutral by addition of Na+ ions. Simulations were carried out
using the Amber 16 and simulation packages. The following systems were subjected to
computational simulations: (i) protein complexes with two Mg2+ ions and ATP, (ii) protein
(wild type and mutants) complexes with two Mg2+ ions and ssDNA. Each system was
simulated at lower (301 K and/or 303 K) and higher (310 K and/or 317) temperature (Table
S3 and Figure S7 in supporting material). The trajectories were analysed using VMD [57],
UCSF Chimera [58], the Cpptraj program from the Amber 16 package [54] and the MOLE
2.5 program [59]. Data were analysed and plotted using the program package R with the
help of libraries ggplot2, data.table and stringr.
Supplementary Materials: The following are available online at https://www.mdpi.com/1422-006
7/22/6/2848/s1.
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